Wedbush ups SpringWorks target to $81, expects Merck KGaA ‘official’ offer soon
Wedbush raised the firm’s price target on SpringWorks Therapeutics (SWTX) to $81 from $77 and keeps an Outperform rating on the shares ...
SpringWorks Therapeutics price target raised to $66 from $63 at TD Cowen
TD Cowen raised the firm’s price target on SpringWorks Therapeutics (SWTX) to $66 from $63 and keeps a Buy rating on the shares. The firm says ...
techxplore19h
NASA's X-59 turns up power, throttles through engine tests
NASA's X-59 quiet supersonic research aircraft has taken another successful step toward flight with the conclusion of a series of engine performance tests.
US FDA approves SpringWorks' genetic disorder drug
The U.S. Food and Drug Administration said on Tuesday it has approved SpringWorks Therapeutics' drug to treat a type of rare ...
U.S. VP Vance and world leaders arrive for Paris AI summit
U.S. Vice President JD Vance warns against over-regulation at a Paris AI summit:::: Paris, France:: "We believe that ...